Cold treatments (CoolSculpting).These employ temperatures cold enough to kill fat cells but not damage your skin. A device pulls portions of skin in by suction, then cools it to destroy the fat underneath for a set amount of time. You can use this procedure on many body parts including the chin, arms, abdomen, love handles and thighs. It’s safe for most patients. However, those who have a vascular condition that makes them extra sensitive to cold temperatures (Raynaud’s syndrome, for instance) should not use this treatment.
The “AXA PPP Group” for this purpose is AXA PPP healthcare Group Limited, its holding company and all subsidiaries of its holding company including (but not limited to) AXA PPP healthcare Limited, AXA ICAS Limited, AXA ICAS Occupational Health Services Limited, Health on Line Company UK Limited and AXA PPP healthcare Administration Services Limited.
Disclosure: This post may contain affiliate links. This means, we may receive a small commission if you choose to purchase something from a link we post (including links to amazon.com because we are a participant in the Amazon Services LLC Associates Program. Don’t worry, it won’t cost you anything. This small percentage just helps us keep the power on and the Diet Coke stocked. We appreciate your support!
Great gym with huge floor space and equipment. Free weights area has lots of benches and Dumbbells for even busy periods. Two racks with 20kg bars, one spare and two smith machines. Couple of half and ez bars too. Upstairs has loads of matrix cardio machines like treadmill, cross trainer, stepper and bikes. Trx suspension area and kettlebells from 4kg to 20kg. Studio for 40 classes a week.
Dr. David P. Rapaport, founder and Medical Director of Coolspa, created Coolspa to address the need in New York for a patient-centric, high quality facility where clients could experience top-tier body contouring in a relaxed, comfortable setting. Most importantly, the Coolspa ethos is based on patient education. Only by being educated about their condition, all relevant treatment options, advantages and disadvantages of those options, can patients make optimal treatment decisions.
1 July 2015: The CMA is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.